Previously studies have suggested that tumors in carriers of rare PTVs are larger23,37,38,39,40 and more likely to be identified as interval rather than screen-detected cancers.37 In the present study, BRCA2-, CHEK2-, and PALB2-associated tumors were larger and more likely to be lymph node positive. The gene discussed is BRCA2; the disease is cancer.